Aegis Therapeutics LLC, a US-based drug delivery technology company, has obtained New Zealand patent providing coverage through December 2029 for fast acting formulations of triptans. The New Zealand patent is the third patent awarded to ...
Tags: Aegis, Fast Acting Formulations
The US Patent and Trademark Office (USPTO) has granted a patent No. 8,329,220 to Aegis Therapeutics' absorption-enhancing self-assembling aqueous hydrogels, designed for delivering peptide and small molecules. The Aegis Hydrogels, which ...
Tags: USPTO, Aegis Therapeutics, aqueous hydrogels
Aegis Therapeutics has received a US patent covering Parathyroid Hormone (PTH) and PTH analogue compositions suitable for metered nasal spray, oral, and injectable delivery. The stabilized PTH formulations incorporate Aegis' ...
Tags: Aegis Therapeutics, PTH formulations, Intravail and ProTek excipients
Aegis Therapeutics has received US patent covering pharmaceutical composition of octreotide. The octreotide formulations incorporate Aegis' Intravail/ProTek excipients suitable for all routes of administration including oral, buccal, ...
Tags: Octreotide Formulations, Aegis Therapeutics, polysorbate surfactants